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Three of the five cases of invasive cancer were in women aged under 35. Over the past decade mortality and incidence rates for cancer of the cervix have increased in younger women, although the rates in those under 25 are still very low compared with those in older women.2' Robertson et al described 10 cases of invasive cancer of the cervix occurring in their study of 1781 women identified with a dyskaryotic smear over 20 years.12 It was not clear, however, whether those cases represented a significant excess or the number to be expected on the basis of the background rate or, indeed, a deficit as no statistical criteria were applied.
Our criteria for reversion to normal were more rigorous than those reported by some workers. We checked on the subsequent outcome of these patients after a further two years. (table) .
The mean (SD) overall variable cost per 100 consultations was £444 (88) (range £329-735). Differences in costs were largely explained by the underlying variation in prescribing behaviour. The number of prescriptions per 100 consultations ranged from 36 to 93 (mean 67 (14) ). A ninefold difference in outpatient referral (mean 6 (2)) also contributed to the observed variation in cost. Differences in the style of practice, as measured by requests for diagnostic tests and radiography, were less important determinants of overall differences in cost. Mean 4-4%. With this higher estimate of referral costs a 10% reduction in prescribing would also result in a 4-5% decrease in overall variable costs. Apportioning certain hospital inpatient costs to the cost of referral would further affect the potential for reducing overall average costs.
Comment
We excluded the costs of repeat prescriptions and took the cost of an outpatient referral as being the cost of one outpatient attendance. On this basis, except in the case of prescribing, the consequences on cost of a change in clinical behaviour might be less than expected. If, however, costs of referral are taken as including costs generated by hospital staff who recall and admit referred patients a different picture emerges.45 Thus agreement on a basis for costing referrals, incorporating a reasonable way of apportioning costs generated by general practitioners and by hospital staff, is needed urgently.
